Research progress of immune checkpoint inhibitors in ovarian cancer
Ovarian cancer is the deadliest malignant tumor in the female reproductive system. Despite advancements in standard treatments such as tumor debulking surgery and platinum-based chemotherapy, the overall survival rate remains low. The emergence of targeted therapies, including Poly(ADP-ribose) polym...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2024-12-01
|
Series: | Exploration of Immunology |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/ei/Article/1003177 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!